5:07 PM
 | 
Apr 12, 2012
 |  BC Extra  |  Company News

Ventana to develop companion diagnostic for Adcetris

Seattle Genetics Inc. (NASDAQ:SGEN) and Millennium Pharmaceuticals Inc. partnered with Ventana Medical Systems Inc. to develop and commercialize a companion diagnostic for cancer drug Adcetris brentuximab vedotin. The partners said the molecular diagnostic will identify patients...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >